| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 76967* | 2014 |
| Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial) PH Jones, MH Davidson, EA Stein, HE Bays, JM McKenney, E Miller, ... The American journal of cardiology 92 (2), 152-160, 2003 | 2222 | 2003 |
| Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease B Pitt, D Waters, WV Brown, AJ van Boven, L Schwartz, LM Title, ... New England Journal of Medicine 341 (2), 70-76, 1999 | 1202 | 1999 |
| The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia JC Fruchart, F Sacks, MP Hermans, G Assmann, WV Brown, R Ceska, ... The American journal of cardiology 102 (10), 1K-34K, 2008 | 939* | 2008 |
| National lipid association recommendations for patient-centered management of dyslipidemia: part 1—full report TA Jacobson, MK Ito, KC Maki, CE Orringer, HE Bays, PH Jones, ... Journal of clinical lipidology 9 (2), 129-169, 2015 | 894 | 2015 |
| Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults DWS Goodman, SB Hulley, LT Clark, CE Davis, V Fuster, JC LaRosa, ... Archives of Internal Medicine 148 (1), 36-69, 1988 | 799 | 1988 |
| Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association HE Bays, PP Toth, PM Kris-Etherton, N Abate, LJ Aronne, WV Brown, ... Journal of clinical lipidology 7 (4), 304-383, 2013 | 660 | 2013 |
| National Lipid Association recommendations for patient-centered management of dyslipidemia: part 2 TA Jacobson, KC Maki, CE Orringer, PH Jones, P Kris-Etherton, G Sikand, ... Journal of clinical lipidology 9 (6), S1-S122. e1, 2015 | 613 | 2015 |
| National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1–executive summary TA Jacobson, MK Ito, KC Maki, CE Orringer, HE Bays, PH Jones, ... Journal of clinical lipidology 8 (5), 473-488, 2014 | 611 | 2014 |
| Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein WV Brown, ML Baginsky Biochemical and biophysical research communications 46 (2), 375-382, 1972 | 610 | 1972 |
| Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation GF Watts, S Gidding, AS Wierzbicki, PP Toth, R Alonso, WV Brown, ... International journal of cardiology 171 (3), 309-325, 2014 | 597 | 2014 |
| Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia RG Bakker-Arkema, MH Davidson, RJ Goldstein, J Davignon, ... Jama 275 (2), 128-133, 1996 | 576 | 1996 |
| Studies of the proteins in human plasma very low density lipoproteins WV Brown, RI Levy, DS Fredrickson Journal of Biological chemistry 244 (20), 5687-5694, 1969 | 535 | 1969 |
| Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins … HN Ginsberg, NA Le, IJ Goldberg, JC Gibson, A Rubinstein, ... The Journal of clinical investigation 78 (5), 1287-1295, 1986 | 503 | 1986 |
| Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists MH Davidson, CM Ballantyne, TA Jacobson, VA Bittner, LT Braun, ... Journal of clinical lipidology 5 (5), 338-367, 2011 | 444 | 2011 |
| Rationale of the Diet-Heart Statement of the American Heart Association| Report of Nutrition Committee SM Grundy, CD Bilheimer, H Blackburn, WV Brown, PO Kwiterovich Jr, ... Nutrition Today 17 (5), 16-20, 1982 | 420 | 1982 |
| Randomized, controlled trial of diabetic patient education: improved knowledge without improved metabolic status ZT Bloomgarden, W Karmally, MJ Metzger, M Brothers, C Nechemias, ... Diabetes care 10 (3), 263-272, 1987 | 378 | 1987 |
| Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey IJ Goldberg, NA Le, JR Paterniti, HN Ginsberg, FT Lindgren, WV Brown The Journal of clinical investigation 70 (6), 1184-1192, 1982 | 287 | 1982 |
| Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial JC Tardif, CM Ballantyne, P Barter, JL Dasseux, ZA Fayad, MC Guertin, ... European heart journal 35 (46), 3277-3286, 2014 | 277 | 2014 |
| Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne S Bershad, A Rubinstein, JR Paterniti Jr, NA Le, SC Poliak, B Heller, ... New England Journal of Medicine 313 (16), 981-985, 1985 | 269 | 1985 |
Ngoc-Anh LeAssociate Professor of Medicine, Emory University在 emory.edu 的電子郵件地址已通過驗證
